Skip to main content

Early melanoma detection can help improve patient outcomes

Melanoma is a type of skin cancer that is common in both men and women. Its ability to spread to other parts of the body makes it one of the most dangerous forms of cancer. But, if melanoma is found early, treatment can be very successful.


Quest Diagnostics offers an extensive patient education program to help with early detection of melanoma and other skin disorders, through our Dermpath Diagnostics® subsidiary. Visit for specific steps that patients can take to conduct self-exams and identify spots that may need to be evaluated by a dermatologist.


Quest also offers dermatopathology services through Dermpath Diagnostics, one of the country’s largest dedicated dermatopathology lab networks with more than 75 board-certified dermatopathologists.

Learn more about our services and our dermatopathologists.

Treatment Selection

Quest Diagnostics offers next-gen sequencing MelanomaSEQ® and MelanomaSEQPlus® Panels, among other testing services, to help physicians develop a treatment plan for navigating within standard of care and clinical trial options.

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.